Patents by Inventor Raghu Kannekanti

Raghu Kannekanti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ready-To-Use Carfilzomib Compositions
    Publication number: 20220072085
    Abstract: The present invention provides a stable, non-aqueous, ready-to-use parenteral composition comprising: carfilzomib or pharmaceutically acceptable salt thereof, acidifying agent, optionally a surfactant, one or more solvents or co-solvents.
    Type: Application
    Filed: November 19, 2021
    Publication date: March 10, 2022
    Applicant: Orbicular Pharmaceutical Technologies Pvt. Ltd.
    Inventors: Mailatur Sivaraman Mohan, Hiren Patel, Bhaveshkumar Vallabhbhai Patel, Raghu Kannekanti, Mohammad Raheesh
  • Ready-to-use Carfilzomib compositions
    Patent number: 11224631
    Abstract: The present invention provides a stable, non-aqueous, ready-to-use parenteral composition comprising: carfilzomib or pharmaceutically acceptable salt thereof, acidifying agent, optionally a surfactant, one or more solvents or co-solvents.
    Type: Grant
    Filed: April 25, 2017
    Date of Patent: January 18, 2022
    Inventors: Mailatur Sivaraman Mohan, Hiren Patel, Bhaveshkumar Vallabhbhai Patel, Raghu Kannekanti, Mohammad Raheesh
  • Stable Liquid Compositions of Melphalan
    Publication number: 20210145778
    Abstract: The present invention relates to a stable non-aqueous, ready to dilute liquid pharmaceutical composition comprising (i) melphalan or a pharmaceutically acceptable salt thereof and (ii) polyoxyethylene sorbitan fatty acid esters; wherein the weight ratio of melphalan to polyoxyethylene sorbitan fatty acid esters is from about 1:0.75 to about 1:20; wherein, composition comprising melphalan, at a concentration of about 50 mg/ml to about 150 mg/ml; wherein, when the composition is diluted to produce melphalan at a concentration of about 0.1 to about 3 mg/ml, is physically and chemically stable up to about 4 hours.
    Type: Application
    Filed: December 27, 2018
    Publication date: May 20, 2021
    Applicants: Orbicular Pharmaceutical Technologies Pvt. Ltd., Orbicular Pharmaceutical Technologies Pvt. Ltd.
    Inventors: Hiren Patel, Bhaveshkumar Vallabhbhai Patel, Raghu Kannekanti, Babuji Kantu, Mahesh Sanka
  • READY-TO-USE CARFILZOMIB COMPOSITIONS
    Publication number: 20190351007
    Abstract: The present invention provides a stable, non-aqueous, ready-to-use parenteral composition comprising: carfilzomib or pharmaceutically acceptable salt thereof, acidifying agent, optionally a surfactant, one or more solvents or co-solvents.
    Type: Application
    Filed: April 25, 2017
    Publication date: November 21, 2019
    Applicant: Orbicular Pharmaceutical Technologies Pvt. Ltd.
    Inventors: Mailatur Sivaraman Mohan, Hiren Patel, Bhaveshkumar Vallabhbhai Patel, Raghu Kannekanti, Mohammad Raheesh